Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/2010
06/23/2010CN101744825A Cefmenoxime hydrochloride preparation and preparation method
06/23/2010CN101744824A Composition preparation of cefathiamidine compound and preparation method thereof
06/23/2010CN101744820A Medicine composite containing dextromethorphan hydrobromide
06/23/2010CN101744815A Composite medicament of omeprazole sodium
06/23/2010CN101744807A Epigallocatechin-3-gallate pharmaceutical composition and freeze-dried powder injection thereof
06/23/2010CN101744800A Nedaplatin medical composition and application
06/23/2010CN101744797A Ibuprofen combination
06/23/2010CN101744791A Method for manufacturing edible film
06/23/2010CN101744789A Biological medicine carrying microcapsule which can degrade nanometer porous polymer L- glutamic acid/ chitosan and preparing method thereof
06/23/2010CN101744788A Omeprazole enteric coated tablet and preparation method thereof
06/23/2010CN101744785A Quick-release tablet and preparation method thereof
06/23/2010CN101744782A Tablet containing faropenem sodium
06/23/2010CN101744781A Gliclazide dispersible tablets and preparation method thereof
06/23/2010CN101744778A Voriconazole phosphate ester for injection and preparation method thereof
06/23/2010CN101744777A Omeprazole sodium freeze-dried powder injection, as well as preparation method and quality control method thereof
06/23/2010CN101744773A Preparation method of bitter-free azithromycin granular composite
06/23/2010CN101744772A Method for preparing drug slow-releasing particulates for animals
06/23/2010CN101744771A Method for preparing solid enrofloxacin nano particles
06/23/2010CN101744768A Protein or nucleic acid drug liposome preparation and preparation method thereof based on tetraether lipid
06/23/2010CN101744767A Thermal sensitive liposome preparation containing camptothecin antineoplastic agents
06/23/2010CN101744766A Preparing technique of nano magnetic gene-loaded liposome of temperature-controlled release
06/23/2010CN101744765A Bulleyaconitine A multivesicular liposome and preparation method thereof
06/23/2010CN101744764A Blank and topotecan hydrochloride containing polycystin liposome and preparation method thereof
06/23/2010CN101744763A Enrofloxacin nano emulsion and method for preparing same
06/23/2010CN101744762A Preparation method of butenafine hydrochloride liniment
06/23/2010CN101744761A Medicament-carried therapeutic ultrasonic coupling gel agent
06/23/2010CN101744760A Sustained release carrier for difficult soluble or easy decomposable drug
06/23/2010CN101744726A Sealing technology of plant capsule
06/23/2010CN101744285A Method for preparing emulsified and gelatinized functional fatty acid carrier
06/23/2010CN101579336B Aztreonam for injection and production method thereof
06/23/2010CN101474159B Creatine phosphate sodium microballoon lyophilized preparation and method for producing the same
06/23/2010CN101292952B Glycyrrhizic acid, biogastrone acid or its salt, derivative temperature sensing gel rubber, preparation method and application thereof
06/23/2010CN101269201B Chinese medicine compound percutaneous absorption patch for treating menorrhalgia and preparation method thereof
06/23/2010CN101224298B Propofol compounds
06/23/2010CN101152190B Orally disintegrating tablets of adefovir dipivoxil and method for preparing the same
06/23/2010CN101138597B Traditional Chinese medicine preparation for preventing and controlling osteoporosis and method of preparing the same
06/23/2010CN101129389B Suppository for treating colitis and method of preparing the same
06/23/2010CN101125916B Biodegradation polymer and its preparing process and application
06/23/2010CN101125187B Traditional Chinese medicinal plaster for treating pulmonary tuberculosis
06/23/2010CN101104015B Olive soft capsule raw material formulation and its preparation technology
06/23/2010CN101053612B External applied traditional Chinese medicine vagina cleaning agent for curing gynecopathy and vagina cleaning ointment thereof
06/23/2010CA2653163A1 Methods for the treatment of acute myeloid leukemia
06/22/2010USRE41390 Trace elements
06/22/2010US7742811 Implantable device and method for the electrical treatment of cancer
06/22/2010US7741474 Solubilising polysaccharides substituted with dydrophilic and hydrophobic groups
06/22/2010US7741465 Chimeric receptor genes and cells transformed therewith
06/22/2010US7741453 Viricides; respiratory synctia virus; parainfluenza virus; simian immunodeficiency virus; complexing drug to blood component; immobilization; storage stability
06/22/2010US7741435 Substance P-saporin (SP-SAP) conjugates and methods of use thereof
06/22/2010US7741375 Polyketal polymers, and methods of making and using same
06/22/2010US7741366 mixing aqueous Solution "A" containing a salt of an organic acid ( sodium citrates, sodium glylcolate, sodium lactate) in presence of a reducing salt of sodium metabisulfites or sodium hydrosulfites with Solution "B" containing aqueous solution of a water soluble H2O2; pH control; antiacne, fungicide
06/22/2010US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation
06/22/2010US7741285 APO-2 ligand/trail formulations
06/22/2010US7741282 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein
06/22/2010US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
06/22/2010US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders
06/22/2010US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM)
06/22/2010US7741268 FDA Orange book listed patent for Follitropin alpha/beta a fertility drug; stable formulation, nonprecipitating, includes Pluronic F68 (aka Poloxamer 188), m-cresol as bacteriostat, diluent
06/22/2010US7741244 Synergistic combination of fatty acid with such as glycolic acid; nonphytotoxic, wide spectrum; safe
06/22/2010US7741072 Polypeptide variants
06/22/2010US7741024 used as immunogens to elicit immune reaction, screening assays, including as antigens to screen antibody libraries, as well as for drug screening and the identification of ligands
06/22/2010US7740884 Freeze-dried FSH/LH formulations
06/22/2010US7740883 reacting mono/di/tri or polycarboxylic acids (e.g.citric acid) with chitosan to form a first solution containing a chitosan nanoparticle that is partially crosslinked to form a core( amide linkage), forming shell on such core having free amino group on the surface with acrylic acid by amidation
06/22/2010US7740882 polyoxyethylene glycol having multiple functional groups, at least one of which is covalently bound to a therapeutic or diagnostic agent (peptide) , and a cell uptake promoter (formyl-met-leu-phe)covalently bound to the therapeutic or diagnostic agent; conjugates; pharmacokinetic; bioavailability
06/22/2010US7740878 Use of betaine to enhance exercise performance
06/22/2010US7740874 A white petrolatum and a methyl glucose dioleate emulsifier selected for its hydrophilic-lipophilic balance, compatibility and as a neutral, nonionic absorption base whose use or permits low production temperatures; especially effective for a hydrocarotizone formulation; cosmetics; stabilizers-free
06/22/2010US7740861 extracted yeast cell wall comprising beta-glucan, a payload molecule(e.g.polynucleotides, polypeptides, proteins, and drugs) and a payload trapping molecule ( e.g polysaccharides, polyamides, polyacrylamide, cationic and anionic polymers, detergents); both in vivo/in vitro delivery of polyload molecule
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740853 Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same
06/22/2010US7740845 Reducing tumor cells; isolated nucleic acids, proteins, peptides, cells, vectors, liposomes, antibodies, transgenic animals; drug screening; imaging, diagnosis
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010US7740463 Pressurised metered dose inhalers (MDI)
06/22/2010CA2542845C Elutable surface coating
06/22/2010CA2495875C Process for producing metered dose inhaler formulations
06/22/2010CA2466868C Oral capsule formulation with increased physical stability
06/22/2010CA2461187C Lyophilized formulation
06/22/2010CA2439062C Silicon implants comprising a radionuclide for use in brachytherapy
06/22/2010CA2434067C Materials and methods relating to protein aggregation in neurodegenerative disease
06/22/2010CA2430829C Rapidly disintegrating tablet comprising an acid-labile active ingredient
06/22/2010CA2423094C Medical compositions, dressings and methods for treating microbial infections of skin lesions
06/22/2010CA2395493C Hyaluronic acid in the treatment of cancer
06/22/2010CA2331086C Hepatitis vaccine
06/22/2010CA2302568C Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
06/22/2010CA2295577C Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumors originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
06/22/2010CA2216963C Tie-2 ligands, methods of making and uses thereof
06/22/2010CA2122745C Bifunctional glycoproteins having a modified carbohydrate complement, and their use in tumor-selective therapy
06/17/2010WO2010068866A2 Therapeutic particles suitable for parenteral administration and methods of making and using same
06/17/2010WO2010068754A2 Methods and compositions for delivery of medicaments to the lungs
06/17/2010WO2010068705A2 Encapsulated agent guided imaging and therapies
06/17/2010WO2010068688A2 System and method for the delivery of a sanitizing foam
06/17/2010WO2010067869A1 Anti-viral agent and anti-viral composition
06/17/2010WO2010067617A1 Lipid membrane structure
06/17/2010WO2010067081A2 Modification of nucleic acid vectors
06/17/2010WO2010067072A1 Rifaximin complexes
06/17/2010WO2010066593A1 Combined drug administration
06/17/2010WO2010066203A1 Controlled releasing composition
06/17/2010WO2010066034A1 Methadone formulation
06/17/2010WO2010041141A3 Oil-based foamable carriers and formulations
06/17/2010WO2010040188A9 Biodegradable polymer - bioactive moiety conjugates
06/17/2010WO2010033598A3 System and method for utilizing microbubbles and liposomes as viral sequestering agents
1 ... 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 ... 1712